Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Hana Tichá"'
Autor:
Hana Tichá
Publikováno v:
East European and Balkan Institute. 42:31-44
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4b1d3ae5dd995fb57caa2fc85027d2f0
https://doi.org/10.19170/eebs.2018.42.2.31
https://doi.org/10.19170/eebs.2018.42.2.31
Autor:
Lukas Bobek, Hana Tichá, Libor Komínek, Jana Zitterbartová, Pavel Krupa, Anna Odlozilikova, Aleš Kudláček, Pavel Šlampa, Radana Dymackova, Tomas Kazda
Publikováno v:
Biomedical Papers, Vol 160, Iss 3, Pp 435-441 (2016)
Background: Hypofractionated accelerated radiotherapy (HART) is now a feasible option for prostate cancer treatment apropos toxicity, biochemical control and shortening of treatment. The aim of this study was to investigate hypofractionated schedules
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5eb50536ae37a603fe7e26013e29ec66
https://biomed.papers.upol.cz/artkey/bio-201603-0016_Early_toxicity_of_hypofractionated_radiotherapy_for_prostate_cancer.php
https://biomed.papers.upol.cz/artkey/bio-201603-0016_Early_toxicity_of_hypofractionated_radiotherapy_for_prostate_cancer.php
Publikováno v:
Reports of Practical Oncology & Radiotherapy. 13(2):62-68
SummaryAims and BackgroundThis study of high-dose-rate brachytherapy to the lumpectomy site as the sole radiation presents longer-term results and toxicity of accelerated partial-breast irradiation, using three-dimensional treatment planning.Material
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d86e76f51ef7a97e677b29606a22b0c
Publikováno v:
Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti. 26(3)
BACKGROUND Anal carcinoma is a rare cancer. Surgical treatment is applied for small superficial tumors of the anal margin, the more advanced disease is treated with concomitant chemoradiotherapy. The aim of our study was to evaluate treatment outcome
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5465ba4ce2de8f56bfc34f1039e8e869
https://pubmed.ncbi.nlm.nih.gov/23763324
https://pubmed.ncbi.nlm.nih.gov/23763324
Autor:
Pavel Krupa, Hana Ticha, Tomas Kazda, Radana Dymackova, Jana Zitterbartova, Anna Odlozilikova, Libor Kominek, Lukas Bobek, Ales Kudlacek, Pavel Slampa
Publikováno v:
Biomedical Papers, Vol 160, Iss 3, Pp 435-441 (2016)
Background: Hypofractionated accelerated radiotherapy (HART) is now a feasible option for prostate cancer treatment apropos toxicity, biochemical control and shortening of treatment. The aim of this study was to investigate hypofractionated schedules
Externí odkaz:
https://doaj.org/article/3436f9adb3a041d78bb6dcd445286129